Skip to main content
Clinical Trials/NCT03151213
NCT03151213
Completed
Phase 4

Effect of Preoperative Administration of Oral Pregabalin on the Postoperative Analgesia in Patients Scheduled for Radiofrequency Ablationof Focal Lesions in the Liver

Sherief Abd-Elsalam1 site in 1 country70 target enrollmentJanuary 1, 2017

Overview

Phase
Phase 4
Intervention
Pregabalin 150mg
Conditions
Hepatocellular Cancer
Sponsor
Sherief Abd-Elsalam
Enrollment
70
Locations
1
Primary Endpoint
visual analogue pain scale (VAS Pain) post operatively
Status
Completed
Last Updated
last month

Overview

Brief Summary

The study aimed to investigate the preemptive analgesia efficacy of of preemptive pregabalin for the postoperative pain management after radiofrequency ablation (RFA) of liver cancer.

Detailed Description

Our data will investigate if preemptive administration of pregabalin will have a role in reducing postoperative pain after radiofrequency ablation (RFA) of liver cancer.

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
June 30, 2017
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sherief Abd-Elsalam
Responsible Party
Sponsor Investigator
Principal Investigator

Sherief Abd-Elsalam

PhDTropical Medicine

Tanta University

Eligibility Criteria

Inclusion Criteria

  • HCC patients, Child A, B, scheduled for Radiofrequency ablation of HCC.

Exclusion Criteria

  • Encephalopathy, Renal impairment

Arms & Interventions

Pregabalin

Pregabalin 150 mg before intervention

Intervention: Pregabalin 150mg

Placebo

Placebo before intervention

Intervention: Placebo

Outcomes

Primary Outcomes

visual analogue pain scale (VAS Pain) post operatively

Time Frame: 2 weeks

Amplitude of pain postoperatively

Study Sites (1)

Loading locations...

Similar Trials